Pharos Capital Group primarily invests $25 to $50 million in healthcare companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations. If you have an investment opportunity which you believe would be a fit for our firm, please reach out at info@pharosfunds.com.

Dallas, TX

3889 Maple Avenue, Suite 400

Dallas, TX 75219

Phone: (214) 855-0194

Fax: (214) 855-1230

Nashville, TN

5511 Virginia Way, Suite 180

Brentwood, TN 37027

Phone: (345) 234-5522

Fax: (345) 263-0234

Baltimore, MD

Phone: (410) 323-1105

Kneeland Youngblood

Co-Founder, Chairman & CEO

About

Kneeland Youngblood is a co-founder of Pharos Capital Group. Today, he leads the firm as its Chairman and CEO, responsible for overall firm strategy and working across Pharos Capital's portfolio companies.

He serves on the investment committees of Pharos’ funds and currently sits on the board of Reel FX.
Mr. Youngblood has held numerous public and private leadership roles, including:
  • Appointment by President Bill Clinton (Senate-confirmed) to the U.S. Enrichment Corporation
  • Appointment to the President’s Intelligence Advisory Board by President Joe Biden
  • Service on major public boards including Starwood Hotels, Burger King, and The Gap
He currently serves on boards including:
  • California Institute of Technology (Caltech)
  • The Milken Institute
  • The Black Economic Alliance
  • Light & Wonder, Inc. (Nasdaq & ASX listed)

Mr. Youngblood is a member of the Council on Foreign Relations.

He earned:
  • A.B. in Political Science, Princeton University
  • M.D., University of Texas Southwestern Medical School
He is based in Dallas.

“We focus on those communities that have the greatest disparities in healthcare because we can generate the best health outcomes for patients, and in doing so, drive toward lower costs and deliver strong returns for investors.”

Kneeland Youngblood